Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GRT-R904 |
| Trade Name | |
| Synonyms | GRTR904|GRT R904 |
| Drug Descriptions |
GRT-R904 is a neoantigen cancer vaccine, which activates cytotoxic T-lymphocyte to kill cancer cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C165515 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Aldesleukin + Anti-KRAS G12D TCR cells + GRT-C903 + GRT-R904 | Aldesleukin Anti-KRAS G12D TCR cells GRT-C903 GRT-R904 | 0 | 1 |
| Aldesleukin + Anti-KRAS G12V TCR cells + GRT-C903 + GRT-R904 | Aldesleukin Anti-KRAS G12V TCR cells GRT-C903 GRT-R904 | 0 | 1 |
| GRT-C903 + GRT-R904 + Ipilimumab + Nivolumab | GRT-C903 GRT-R904 Ipilimumab Nivolumab | 0 | 1 |
| GRT-R904 | GRT-R904 | 0 | 0 |